Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 Erasca (ERAS) will also present potential first-in-class examples of direct SMP ...
WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...
Affimed N.V., a clinical-stage immuno-oncology company, announced that an abstract on its phase 2 LuminICE-203 study involving the innate cell engager acimtamig in combination with AlloNK has been ...
The Biennial Conference on Chemical Education 2026 (BCCE 2026) is seeking abstract submissions from educators, researchers, and practitioners. This includes for in-person oral presentations and global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results